News
NPCE
16.53
+0.36%
0.06
Weekly Report: what happened at NPCE last week (0622-0626)?
Weekly Report · 1d ago
Weekly Report: what happened at NPCE last week (0615-0619)?
Weekly Report · 06/22 09:19
Weekly Report: what happened at NPCE last week (0608-0612)?
Weekly Report · 06/15 09:19
NeuroPace (NPCE) Down 0.6% Since Last Earnings Report: Can It Rebound?
NASDAQ · 06/11 15:30
NeuroPace Shareholders Approve Directors and Auditor at Meeting
TipRanks · 06/08 22:26
Weekly Report: what happened at NPCE last week (0601-0605)?
Weekly Report · 06/08 09:18
Weekly Report: what happened at NPCE last week (0525-0529)?
Weekly Report · 06/01 09:19
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)
TipRanks · 05/29 13:31
NeuroPace announces FDA approval of ECoG Assistant
TipRanks · 05/29 13:15
NeuroPace To Highlight Expanding Role Of Responsive Neuromodulation In Epilepsy Care In 2026 ASSFN Meeting
Benzinga · 05/29 12:13
NeuroPace attends ASSFN meeting, spotlights expanding role of responsive neuromodulation in epilepsy care
PUBT · 05/29 12:06
NeuroPace wins FDA approval for ECoG Assistant AI epilepsy feature
PUBT · 05/29 12:01
NEUROPACE ANNOUNCES FDA APPROVAL OF ECOG ASSISTANT™, ADVANCING AI-DRIVEN EPILEPSY CARE
Reuters · 05/29 12:00
NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
Barchart · 05/29 07:05
NeuroPace Announces FDA Approval of ECoG Assistant™, Advancing AI-Driven Epilepsy Care
Barchart · 05/29 07:00
Is NPCE Stock a Buy in 2026 After DIXI Exit and Margin Lift?
NASDAQ · 05/27 14:58
NPCE Explains How NeuroPace's RNS System Makes Money
NASDAQ · 05/27 14:45
NeuroPace NPCE and the Next Wave of AI-Driven Epilepsy Care
NASDAQ · 05/27 14:34
Analysts Conflicted on These Healthcare Names: NeoGenomics (NEO) and NeuroPace (NPCE)
TipRanks · 05/27 09:40
Weekly Report: what happened at NPCE last week (0518-0522)?
Weekly Report · 05/25 09:20
More
Webull provides a variety of real-time NPCE stock news. You can receive the latest news about Neuropace Inc through multiple platforms. This information may help you make smarter investment decisions.
About NPCE
NeuroPace, Inc. is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. The Company's RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. This platform can drive a better standard of care for patients living with drug-resistant epilepsy and has the potential to offer a more personalized solution and improved outcomes to the large population of patients suffering from other brain disorders. The Company's RNS System includes its RNS neurostimulator, its cortical strip leads and depth leads, and its Patient Remote Monitor, as well as other implantable and non-implantable accessories. The Company's product offerings also include Physician Tablet, Patient Data Management System (PDMS) and nSight Platform, which facilitate ongoing patient monitoring and streamline patient support. The PDMS is an online database.